$Pistol Pete$, $Mick$ & Friends Stock Picks /news, DD and charts

[DewmBoom]

$MJNA: Kannalife Featured Tonight at Dateline NBC....MJNA Owns 36% of Kannalife

Kannalife Sciences, Inc. As of December 31, 2017, the Company owns an approximate 36% equity stake in Kannalife Sciences, Inc. (“Kannalife”). Kannalife is a biopharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife currently holds two licenses with National Institutes of Health – Office of Technology Transfer for the Commercialization of U.S. Patent #6630507, “Cannabinoids as Antioxidants and Neuroprotectants”. The first license, issued in June 2012, is an exclusive license to develop commercial drug candidates for the treatment of Hepatic Encephalopathy (“HE”). The second license, issued in July 2014, is a license to develop commercial drug candidates for the treatment of Chronic Traumatic Encephalopathy (“CTE”). KannaLife is currently conducting research and development at the Bucks County Pennsylvania Biotechnology Center in Doylestown, PA, and has filed its first PCT (“Patent Cooperation Treaty”) Application with the United States Patent and Trademark Office (the “USPTO”) for an international patent covering Kannalife’s novel cannabidiol-like target drug candidates for the treatment of certain neurological disorders and as a novel neuroprotectant for the treatment of HE and CTE. HE and CTE are both neurodegenerative and oxidative stress related diseases that affects the hippocampus which controls cognitive and behavioral functions in humans.

https://globenewswire.com/news-release/2018/05/18/1508858/0/en/Kannalife-Sciences-to-be-Featured-in-Dateline-NBC-Segment-Covering-Company-s-Research-on-CBD-Like-Molecules-as-Treatments-for-HE-CTE.html